SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-005142
Filing Date
2024-07-01
Accepted
2024-07-01 16:42:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3550
  Complete submission text file 0001950047-24-005142.txt   5014
Mailing Address
Business Address
KARABELAS ARGERIS N (Reporting) CIK: 0001191229 (see all company filings)

Type: 144

Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Subject) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37553 | Film No.: 241091289
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)